Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Liraglutide – Next-Generation Antidiabetic Medication

Drug (Brand/Generic)

Liraglutide

Company/Licensee

Novo Nordisk

Therapy Class

GLP-1 analogue

Product Description

Long-acting human analogue of naturally occurring hormone, GLP-1

Current Indication

Type 2 diabetic patients poorly controlled with diet plus metformin and/or sulfonylureas

Market Sector

Diabetes

Development Status

Approved Europe, US and Japan
Expand

Go Top